Modulation of astrocyte glutamate transporters decreases seizures in a mouse model of Tuberous Sclerosis Complex

Astrocyte dysfunction may contribute to epileptogenesis and other neurological deficits in Tuberous Sclerosis Complex (TSC). In particular, decreased expression and function of astrocyte glutamate transporters have been implicated in causing elevated extracellular glutamate levels, neuronal death, a...

Full description

Bibliographic Details
Main Authors: Ling-Hui Zeng, Adam W. Bero, Bo Zhang, David M. Holtzman, Michael Wong
Format: Article
Language:English
Published: Elsevier 2010-03-01
Series:Neurobiology of Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996109003751
_version_ 1818616222571298816
author Ling-Hui Zeng
Adam W. Bero
Bo Zhang
David M. Holtzman
Michael Wong
author_facet Ling-Hui Zeng
Adam W. Bero
Bo Zhang
David M. Holtzman
Michael Wong
author_sort Ling-Hui Zeng
collection DOAJ
description Astrocyte dysfunction may contribute to epileptogenesis and other neurological deficits in Tuberous Sclerosis Complex (TSC). In particular, decreased expression and function of astrocyte glutamate transporters have been implicated in causing elevated extracellular glutamate levels, neuronal death, and epilepsy in a mouse model of TSC (Tsc1GFAPCKO mice), involving inactivation of the Tsc1 gene primarily in astrocytes. Here, we tested whether pharmacological induction of astrocyte glutamate transporter expression can prevent the neurological phenotype of Tsc1GFAPCKO mice. Early treatment with ceftriaxone prior to the onset of epilepsy increased expression of astrocyte glutamate transporters, decreased extracellular glutamate levels, neuronal death, and seizure frequency, and improved survival in Tsc1GFAPCKO mice. In contrast, late treatment with ceftriaxone after onset of epilepsy increased glutamate transporter expression, but had no effect on seizures. These results indicate that astrocyte glutamate transporters contribute to epileptogenesis in Tsc1GFAPCKO mice and suggest novel therapeutic strategies for epilepsy in TSC directed at astrocytes.
first_indexed 2024-12-16T16:46:22Z
format Article
id doaj.art-d8f4d316b009473e83ea0e5f23b98b5b
institution Directory Open Access Journal
issn 1095-953X
language English
last_indexed 2024-12-16T16:46:22Z
publishDate 2010-03-01
publisher Elsevier
record_format Article
series Neurobiology of Disease
spelling doaj.art-d8f4d316b009473e83ea0e5f23b98b5b2022-12-21T22:24:11ZengElsevierNeurobiology of Disease1095-953X2010-03-01373764771Modulation of astrocyte glutamate transporters decreases seizures in a mouse model of Tuberous Sclerosis ComplexLing-Hui Zeng0Adam W. Bero1Bo Zhang2David M. Holtzman3Michael Wong4Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USADepartment of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USADepartment of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USADepartment of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA; Developmental Biology, Washington University School of Medicine, St. Louis, MO 63110, USA; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO 63110, USADepartment of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA; Anatomy and Neurobiology, Washington University School of Medicine, St. Louis, MO 63110, USA; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO 63110, USA; Corresponding author. Department of Neurology, Box 8111, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, USA. Fax: +1 314 362 9462.Astrocyte dysfunction may contribute to epileptogenesis and other neurological deficits in Tuberous Sclerosis Complex (TSC). In particular, decreased expression and function of astrocyte glutamate transporters have been implicated in causing elevated extracellular glutamate levels, neuronal death, and epilepsy in a mouse model of TSC (Tsc1GFAPCKO mice), involving inactivation of the Tsc1 gene primarily in astrocytes. Here, we tested whether pharmacological induction of astrocyte glutamate transporter expression can prevent the neurological phenotype of Tsc1GFAPCKO mice. Early treatment with ceftriaxone prior to the onset of epilepsy increased expression of astrocyte glutamate transporters, decreased extracellular glutamate levels, neuronal death, and seizure frequency, and improved survival in Tsc1GFAPCKO mice. In contrast, late treatment with ceftriaxone after onset of epilepsy increased glutamate transporter expression, but had no effect on seizures. These results indicate that astrocyte glutamate transporters contribute to epileptogenesis in Tsc1GFAPCKO mice and suggest novel therapeutic strategies for epilepsy in TSC directed at astrocytes.http://www.sciencedirect.com/science/article/pii/S0969996109003751EpilepsySeizureGliaGLT-1CeftriaxoneEpileptogenesis
spellingShingle Ling-Hui Zeng
Adam W. Bero
Bo Zhang
David M. Holtzman
Michael Wong
Modulation of astrocyte glutamate transporters decreases seizures in a mouse model of Tuberous Sclerosis Complex
Neurobiology of Disease
Epilepsy
Seizure
Glia
GLT-1
Ceftriaxone
Epileptogenesis
title Modulation of astrocyte glutamate transporters decreases seizures in a mouse model of Tuberous Sclerosis Complex
title_full Modulation of astrocyte glutamate transporters decreases seizures in a mouse model of Tuberous Sclerosis Complex
title_fullStr Modulation of astrocyte glutamate transporters decreases seizures in a mouse model of Tuberous Sclerosis Complex
title_full_unstemmed Modulation of astrocyte glutamate transporters decreases seizures in a mouse model of Tuberous Sclerosis Complex
title_short Modulation of astrocyte glutamate transporters decreases seizures in a mouse model of Tuberous Sclerosis Complex
title_sort modulation of astrocyte glutamate transporters decreases seizures in a mouse model of tuberous sclerosis complex
topic Epilepsy
Seizure
Glia
GLT-1
Ceftriaxone
Epileptogenesis
url http://www.sciencedirect.com/science/article/pii/S0969996109003751
work_keys_str_mv AT linghuizeng modulationofastrocyteglutamatetransportersdecreasesseizuresinamousemodeloftuberoussclerosiscomplex
AT adamwbero modulationofastrocyteglutamatetransportersdecreasesseizuresinamousemodeloftuberoussclerosiscomplex
AT bozhang modulationofastrocyteglutamatetransportersdecreasesseizuresinamousemodeloftuberoussclerosiscomplex
AT davidmholtzman modulationofastrocyteglutamatetransportersdecreasesseizuresinamousemodeloftuberoussclerosiscomplex
AT michaelwong modulationofastrocyteglutamatetransportersdecreasesseizuresinamousemodeloftuberoussclerosiscomplex